1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Buprenorphine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Morphine
1.2.6 Oxycodone
1.2.7 Tramadol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Opioid Drugs Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Anesthesia
1.3.3 Pain relief
1.3.4 Cough suppression
1.3.5 Diarrhea suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Opioid Drugs Market Perspective (2018-2032)
2.2 Opioid Drugs Growth Trends by Region
2.2.1 Opioid Drugs Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Opioid Drugs Historic Market Size by Region (2018-2023)
2.2.3 Opioid Drugs Forecasted Market Size by Region (2023-2032)
2.3 Opioid Drugs Market Dynamics
2.3.1 Opioid Drugs Industry Trends
2.3.2 Opioid Drugs Market Drivers
2.3.3 Opioid Drugs Market Challenges
2.3.4 Opioid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Drugs Players by Revenue
3.1.1 Global Top Opioid Drugs Players by Revenue (2018-2023)
3.1.2 Global Opioid Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Drugs Revenue
3.4 Global Opioid Drugs Market Concentration Ratio
3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2022
3.5 Opioid Drugs Key Players Head office and Area Served
3.6 Key Players Opioid Drugs Product Solution and Service
3.7 Date of Enter into Opioid Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Drugs Breakdown Data by Type
4.1 Global Opioid Drugs Historic Market Size by Type (2018-2023)
4.2 Global Opioid Drugs Forecasted Market Size by Type (2023-2032)
5 Opioid Drugs Breakdown Data by Application
5.1 Global Opioid Drugs Historic Market Size by Application (2018-2023)
5.2 Global Opioid Drugs Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Opioid Drugs Market Size (2018-2032)
6.2 North America Opioid Drugs Market Size by Country (2018-2023)
6.3 North America Opioid Drugs Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Opioid Drugs Market Size (2018-2032)
7.2 Europe Opioid Drugs Market Size by Country (2018-2023)
7.3 Europe Opioid Drugs Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Drugs Market Size (2018-2032)
8.2 Asia-Pacific Opioid Drugs Market Size by Country (2018-2023)
8.3 Asia-Pacific Opioid Drugs Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Opioid Drugs Market Size (2018-2032)
9.2 Latin America Opioid Drugs Market Size by Country (2018-2023)
9.3 Latin America Opioid Drugs Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Drugs Market Size (2018-2032)
10.2 Middle East & Africa Opioid Drugs Market Size by Country (2018-2023)
10.3 Middle East & Africa Opioid Drugs Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Detail
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2018-2023)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Cipher Pharmaceutical Inc.
11.2.1 Cipher Pharmaceutical Inc. Company Detail
11.2.2 Cipher Pharmaceutical Inc. Business Overview
11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2018-2023)
11.2.5 Cipher Pharmaceutical Inc. Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Detail
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Opioid Drugs Introduction
11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2018-2023)
11.3.5 Daiichi Sankyo Recent Development
11.4 Johnson?Johnson
11.4.1 Johnson?Johnson Company Detail
11.4.2 Johnson?Johnson Business Overview
11.4.3 Johnson?Johnson Opioid Drugs Introduction
11.4.4 Johnson?Johnson Revenue in Opioid Drugs Business (2018-2023)
11.4.5 Johnson?Johnson Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Detail
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Opioid Drugs Introduction
11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2018-2023)
11.5.5 Lupin Limited Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Opioid Drugs Introduction
11.6.4 Pfizer Revenue in Opioid Drugs Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Detail
11.7.2 Sun Pharmaceuticals Business Overview
11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2018-2023)
11.7.5 Sun Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2018-2023)
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
